Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1868094

CCCCCCCCCCCCCCCC[P+](CC)(CC)CC.[Cl-]

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BDKRB2 known ✓ P30411 4/20 0.45
DNM1 Q05193 6/20 0.68
TSHR P16473 1/20 0.47
THRB P10828 1/20 0.47
LMNA P02545 1/20 0.40
OPRM1 P35372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3781268 1.00 DNM1 (0.68) DNM1TSHRTHRBBDKRB2LMNA
Hydrochloric Acid SCHEMBL5085185 1.00 DNM1 (0.68) DNM1TSHRTHRBBDKRB2LMNA
Hydrochloric Acid SCHEMBL5087808 1.00 DNM1 (0.68) DNM1TSHRTHRBBDKRB2LMNA
Hydrochloric Acid SCHEMBL5087731 1.00 DNM1 (0.68) DNM1TSHRTHRBBDKRB2LMNA
Hydrochloric Acid SCHEMBL5085420 1.00 DNM1 (0.68) DNM1TSHRTHRBBDKRB2LMNA
Hydrochloric Acid SCHEMBL1864955 1.00 DNM1 (0.68) DNM1TSHRTHRBBDKRB2LMNA
Hydrochloric Acid SCHEMBL5085071 1.00 DNM1 (0.68) DNM1TSHRTHRBBDKRB2LMNA
Hydrochloric Acid SCHEMBL11119620 1.00 DNM1 (0.68) DNM1TSHRTHRBBDKRB2LMNA
Hydrochloric Acid SCHEMBL10616392 1.00 DNM1 (0.68) DNM1TSHRTHRBBDKRB2LMNA
Hydrochloric Acid SCHEMBL5087650 1.00 DNM1 (0.68) DNM1TSHRTHRBBDKRB2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3040421-B1 METHOD FOR MEASURING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN, AND REAGENT FOR USE IN SAID METHOD SEKISUI MEDICAL CO LTD (JP) 2018-03-28 EP disclosed
EP-2949650-B1 Synthetic method for the preparation of 1,2-Benzisothiazolin-3-one SHOUGUANG SYNTECH FINE CHEMICAL CO LTD (CN) 2017-10-11 EP disclosed
US-20160208311-A1 METHOD FOR MEASURING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN, AND REAGENT FOR USE IN SAID METHOD SEKISUI MEDICAL CO., LTD. (JP) 2016-07-21 US disclosed
EP-3040421-A1 METHOD FOR MEASURING CHOLESTEROL IN HIGH-DENSITY LIPOPROTEIN, AND REAGENT FOR USE IN SAID METHOD Sekisui Medical Co., Ltd. (JP) 2016-07-06 EP disclosed
US-9334248-B2 Synthetic method for the preparation of 1, 2-benzisothiazolin-3-one SHOUGUANG SYNTECH FINE CHEMICAL CO., LTD. (CN) 2016-05-10 US disclosed
US-9221740-B2 Method for producing carbonate compound and method for producing aromatic polycarbonate ASAHI GLASS COMPANY, LIMITED (JP) 2015-12-29 US disclosed
EP-2949650-A1 Synthetic method for the preparation of 1,2-Benzisothiazolin-3-one Shouguang Syntech Fine Chemical Co., Ltd. (CN) 2015-12-02 EP disclosed
US-20150336910-A1 SYNTHETIC METHOD FOR THE PREPARATION OF 1, 2-BENZISOTHIAZOLIN-3-ONE SYNTECH EURO LIMITED (GB) 2015-11-26 US disclosed
EP-2883861-A1 METHOD FOR PRODUCING CARBONATE COMPOUND AND METHOD FOR PRODUCING AROMATIC POLYCARBONATE Asahi Glass Company, Limited (JP) 2015-06-17 EP disclosed
US-20150152037-A1 METHOD FOR PRODUCING CARBONATE COMPOUND AND METHOD FOR PRODUCING AROMATIC POLYCARBONATE AGC Inc. (JP) 2015-06-04 US disclosed
WO-2011053470-A2 SELECTIVE SILICON ETCH PROCESS SACHEM, INC. (US) 2011-05-05 WO disclosed
US-20110104875-A1 SELECTIVE SILICON ETCH PROCESS PNC BANK, NATIONAL ASSOCIATION 2011-05-05 US disclosed
US-20080214386-A1 Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2008-09-04 US disclosed
EP-0332729-A1 Vulcanizable chlorinated polyethylene compositions E.I. DU PONT DE NEMOURS AND COMPANY (US) 1989-09-20 EP disclosed
US-4749521-A REACTING 1,4-DIAMINO-2,3-DIHALOGENOANTHRAQUINONE WITH SULFONATING AGENT IN PRESCENCE OF QUATERNARY AMMONIUM OR PHOSPHONIUM COMPOUND SUMITOMO CHEMICAL COMPANY, LTD. (JP) 1988-06-07 US disclosed
US-4745147-A SULFUR COMPOUND CURING AGENT E. I. DU PONT DE NEMOURS AND COMPANY (US) 1988-05-17 US disclosed
EP-0105762-B1 PROCESS FOR PRODUCING ANTHRAQUINONE COMPOUNDS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-03-09 EP disclosed
US-4710320-A REACTING 1-AMINO-2-HALOGENO-4-HYDROXYANTHRAQUINONES WITH PHENOLS IN A SULFOLANE SOLVENT WITH AN ACID BINDING AGENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1987-12-01 US disclosed
US-4519947-A SULFONATING 1,4-DIAMINO-2,3-DIHALOGENO-ANTHRAQUINONE SUMITOMO CHEMICAL CO., LTD. (JP) 1985-05-28 US disclosed
EP-0105762-A2 Process for producing anthraquinone compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1984-04-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152037-A1 METHOD FOR PRODUCING CARBONATE COMPOUND AND METHOD FOR PRODUCING AROMATIC POLYCARBONATE PKD1, CA2, CA11 BDKRB2 1479/4885DNM1 906/4885TSHR 3475/4885
US-20150336910-A1 SYNTHETIC METHOD FOR THE PREPARATION OF 1, 2-BENZISOTHIAZOLIN-3-ONE TST, AQP1, BZW1 BDKRB2 1940/4885DNM1 3268/4885TSHR 256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.